Dihexa
Oral oligopeptide derivative discussed for synaptic plasticity preclinical models.
Overview
Experimental compound with oncologic theoretical concerns in literature.
What it is
Synthetic N-hexanoic derivative of angiotensin IV analog.
Mechanism (high level)
Hepatocyte growth factor / synaptogenesis themes in rodent cognition models.
Quick facts
- Dosage
- No safe human dosing established
- Route
- Oral in research discussion
- Cycle
- Not standardized
- Storage
- Room temperature
Research indications
- Cognition preclinical models
Research protocols (education)
Education-first logging template
Use PepTok to track adherence and notes; any protocol must be directed by a qualified clinician.
Interactions
Often avoided with
- Use during pregnancy or malignancy history
Often combined with
- Cognitive rehabilitation
Peptides discussed online are not substitutes for diagnosis or prescriptions.
Side effects & safety
- Unknown human safety; theoretical oncologic signaling concerns in preclinical work.
Regulatory notes
- Not approved drug; research chemical status.
FAQ
Is this a prescription?
PepTok does not provide prescriptions; it is for logging and education.
Related in catalog
Track in app
Save favorites, compare protocols, and track over time
PepTok gives you structure: stacks, reminders, notes, and progress snapshots in one place.
Educational content only. This material is not medical advice. Verify legality, sourcing, and dosing with a qualified professional.